Morning Alert : NVIDIA Corporation (NASDAQ:NVDA), SandRidge Energy, Inc. (NYSE:SD), BioLife (NASDAQ:BLFS), Kelly Services, Inc. (NASDAQ:KELYA), OncoGenex Pharmaceuticals (NASDAQ:OGXI)

QUALCOMM, Inc. (NASDAQ:QCOM), NVIDIA Corporation (NASDAQ:NVDA) and Intel Corporation (NASDAQ:INTC) are the three new entrants that can significantly contribute in the Automotive Head-unit Processor Revenues. As per ABI Research, the three entrants can push the revenues to as much as $1.95 Billion by 2020. NVIDIA Corporation (NASDAQ:NVDA) belongs to Technology sector. Its net profit margin is 11.70% and weekly performance is 1.69%. On last trading day company shares ended up $19.25. NVIDIA Corporation (NASDAQ:NVDA) distance from 50-day simple moving average (SMA50) is 3.46%.

SandRidge Energy, Inc. (NYSE:SD) announced the resignation of David Lawler, Executive Vice President and Chief Operating Officer. The company has promoted Craig Johnson, Senior Vice President of Development for Oklahoma, to Executive Vice President of Operations. Lawler will remain engaged in his current role through September 3rd to ensure a smooth transition. The company has initiated a search for a new Chief Operating Officer. SandRidge Energy, Inc. (NYSE:SD) shares moved down -1.52% in last trading session and ended the day at $5.17. SD Gross Margin is 68.40% and its return on assets is -3.60%. SandRidge Energy, Inc. (NYSE:SD) quarterly performance is -23.52%.

BioLife Solutions (NASDAQ:BLFS)’s stock had its “outperform” rating reiterated by Zacks in a research report issued to clients and investors on Friday, 08 Aug 2014. They currently have a $7.50 target price on the stock. Zacks‘s target price suggests a potential upside of 203.64% from the stock’s previous close. On 20 August, BioLife Solutions, Inc. (NASDAQ:BLFS) shares increased 2.43% and was closed at $2.11. BLFS EPS growth in last 5 year was 17.00%. BioLife Solutions, Inc. (NASDAQ:BLFS) year to date (YTD) performance is -74.88%.

On August 5, 2014, upon the recommendation of its Compensation Committee, the Board of Directors of Kelly Services, Inc. (NASDAQ:KELYA) approved an amendment to the Kelly Services, Inc. 2008 Management Retirement Plan (the “2008 Plan”), effective as of January 1, 2015, to increase Company matching contributions from 50% of the first 8% of employee compensation deferrals made to the 2008 Plan (for a net 4% match) to 50% of the first 10% of employee compensation deferrals made to the 2008 Plan (for a net 5% match). Further, in light of the foregoing increase to the Company matching contribution, the Board approved that the Company would no longer make discretionary Company retirement contributions to the 2008 Plan, effective January 1, 2015. Kelly Services, Inc. (NASDAQ:KELYA) ended the last trading day at $16.33. Company weekly volatility is calculated as 2.81%and price to cash ratio as 10.62. Kelly Services, Inc. (NASDAQ:KELYA) showed a weekly performance of 2.96%.

OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) CEO Scott Daniel Cormack unloaded 18,341 shares of the stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $3.17, for a total value of $58,140.97. Following the completion of the sale, the chief executive officer now directly owns 84,139 shares in the company, valued at approximately $266,721. OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) shares moved down -1.83% in last trading session and ended the day on $3.21. OGXI return on assets is -54.80%. OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) quarterly performance is -14.17%.